Anisomycin

From Wikipedia, the free encyclopedia

The structure of Anisomycin
The structure of Anisomycin


Anisomycin, also known as Flagecidin (IUPAC name: 3,4-Pyrrolidinediol, 2-[(4-methoxyphenyl)methyl]-, 3-acetate, (2R,3S,4S)-) is an antibiotic produced by Streptomyces griseolus which inhibits protein synthesis. Partial inhibition of DNA synthesis occurs at anisomycin concentrations that effect 95% inhibition of protein synthesis [1]. Anisomycin can activate stress-activated protein kinases, MAP kinase and other signal transduction pathways.

Anisomycin is inactive against bacteria.

Contents

[edit] Pharmacology

Anisomycin interferes with protein and DNA synthesis by inhibiting peptidyl transferase or the 80S ribosome system.

Anisomycin is also mentioned as a potential psychiatric drug, as it may erase "short-range memory" [2].

Injection of anisomycin into the hippocampus has been proposed for selective removal of memories [3].


[edit] References

1. Image:Free_text.png Inhibitors of protein biosynthesis. II. Mode of action of anisomycin. 1967 Jul 10; PubMed Free text (PDF - 990K)
2. Memory for context is impaired by injecting anisomycin into dorsal hippocampus following context exploration. 2002 Aug 21; PubMed
3. Image:Free_text.png Consolidation and reconsolidation of incentive learning in the amygdala. ; PubMed Free text

[edit] See also

[edit] External links